ACH
Accendra Health, Inc.
ACH trails on the overall score without a compensating advantage in the available component scores.
LLY
Eli Lilly and Company
LLY has the edge over ACH overall, supported by stronger fundamentals and stronger valuation.
ACH Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Under pressure | |
| Weak |
ACH's profitability is currently stable, but its revenue, cash flow and balance sheet are under pressure.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
ACH PE Valuation
ACH has no meaningful PE right now: it lost money over the past year.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
ACH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Stable | |
| Weakening | |
| Limited | |
| High |
Analysts expect ACH's earnings and profitability to decline, with its revenue holding steady.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
LLY has the edge over ACH on the outlook, with more favorable earnings and revenue expectations.
ACH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.24 | +$15.17 |
| Q2 2026 | -$3.93 | +$11.71 |
| Q1 2026 | -$14.07 | -$9.31 |
| Q4 2025 | -$14.31 | -$9.58 |
| Q3 2025 | -$17.41 | -$16.76 |
| Q2 2025 | -$15.64 | -$15.08 |
| Q1 2025 | -$4.76 | -$4.25 |
| Q4 2024 | -$4.73 | -$4.19 |
ACH is still losing money, but far less than before: $2.24 per share over the past year, against $17.41 at its worst in late 2025.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.83 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over ACH on earnings quality, reporting a profit while its opponent remains loss making.
ACH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $601.8M | -14% |
| Q2 2026 | $613.2M | -10% |
| Q1 2026 | $627.8M | -76% |
| Q4 2025 | $709M | -74% |
| Q3 2025 | $697.3M | -74% |
| Q2 2025 | $681.9M | -74% |
| Q1 2025 | $2.6B | +0.7% |
| Q4 2024 | $2.7B | +1.5% |
ACH's revenue has slid since its 2024 peak: $602M last quarter, down 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0.2% | -3.6 points |
| Q2 2026 | -5.7% | +0.1 points |
| Q1 2026 | 2.7% | +2.7 points |
| Q4 2025 | 3% | +13 points |
| Q3 2025 | 3.8% | +2.9 points |
| Q2 2025 | -5.8% | -6.6 points |
| Q1 2025 | 0% | -0.4 points |
| Q4 2024 | -9.7% | -12 points |
ACH's operating margin was 0.2% last quarter, down 3.6 points from the same quarter a year ago.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over ACH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over ACH on profitability, with a higher operating margin.
ACH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$56.6M | +$170.2M |
| Q1 2026 | -$91.7M | -$56.7M |
| Q4 2025 | $55.1M | +574% |
| Q3 2025 | -$226.8M | -$192.6M |
| Q1 2025 | -$35.1M | +$63.9M |
| Q4 2024 | $8.2M | -87% |
| Q3 2024 | -$34.2M | -132% |
| Q2 2024 | $70.3M | -73% |
ACH has burned cash in six of the last eight quarters: −$167M over the past year, against −$288M the year before.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over ACH on cash generation, producing positive trailing cash flow while its opponent burns cash.
ACH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +214K shares |
| 1 year | -0.5% | -379K shares |
| 3 years | +0.9% | +706K shares |
| 5 years | +1.3% | +951K shares |
| Available history | +27% | +16.3M shares |
ACH has 77M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
| Q4 2025 | $3.5M |
| Q3 2025 | — |
| Q2 2025 | $5.2M |
| Q1 2025 | $1.5M |
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over ACH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
ACH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 8.6x | High |
| Q2 2026 | 6.8x | High |
| Q1 2026 | 7.4x | High |
| Q4 2025 | 8.0x | High |
| Q1 2025 | 54.7x | High |
| Q4 2024 | 31.7x | High |
| Q3 2024 | 4.8x | High |
| Q2 2024 | 4.6x | High |
ACH's net debt is about 8.6 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY has the edge over ACH on leverage, with a lower net debt burden relative to earnings.
ACH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 24.1 | Oversold |
| Stochastic | 1.0 | Oversold |
ACH's weekly RSI is 24 (oversold) and its Stochastic is 1 (oversold).
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
ACH PE vs Healthcare Sector
| Metric | ACH | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
ACH has no meaningful PE right now: it lost money over the past year.
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
ACH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.34 | 56% below |
| 20 week MA | $1.44 | 90% below |
| 50 week MA | $2.21 | 93% below |
| 100 week MA | $4.90 | 97% below |
| 200 week MA | $11.4 | 99% below |
ACH is in a downtrend: it's below all five of its weekly moving averages, and 99% below its 200-week average.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over ACH on trend strength, trading above more of its moving averages.
ACH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.08 | $30.3 | +497% |
| 2021 | $30.3 | $43.7 | +44% |
| 2022 | $43.7 | $19.5 | -55% |
| 2023 | $19.5 | $19.3 | -1% |
| 2024 | $19.3 | $13.0 | -33% |
| 2025 | $13.0 | $2.77 | -79% |
| 2026 YTD | $2.77 | $0.15 | -95% |
ACH has finished four years in a row lower, and it's down 95% so far in 2026.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over ACH on returns for 2026, with the stronger performance.